Hydroxychloroquine sulfate How Supplied
| Hydroxychloroquine sulfate |
|---|
| HYDROXYCHLOROQUINE SULFATE® FDA Package Insert |
| Description |
| Clinical Pharmacology |
| Microbiology |
| Indications And Usage |
| Contraindications |
| Warnings And Precautions |
| Adverse Reactions |
| Overdosage |
| Dosage And Administration |
| How Supplied |
| Labels And Packages |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
How Supplied
Hydroxychloroquine sulfate tablets, USP are white, to off-white, capsule-shaped tablets, debossed with "HCQS" on one side and plain on the reverse side and are available in bottles of 10, 100, 500 and 1000. Each tablet contains 200 mg hydroxychloroquine sulfate, USP (equivalent to 155 mg base).
NDC 63304-296-03 Bottles of 10
NDC 63304-296-01 Bottles of 100
NDC 63304-296-05 Bottles of 500
NDC 63304-296-10 Bottles of 1000
Dispense in a tight, light-resistant container as defined in the USP/NF.
Store at 20° - 25°C (68° - 77°F) excursions permitted to 15° - 30°C (59° - 86°F) [See USP Controlled Room Temperature].
Call your doctor for medical advice about side effects. You may report side effects at 1-800-FDA-1088.
Manufactured for:
Ranbaxy Pharmaceuticals Inc.
Jacksonville, FL 32257 USA
By: Ipca Laboratories Limited
48, Kandivli Ind. Estate, Mumbai 400 067, India
May 2009[1]
References
Adapted from the FDA Package Insert.